Drug Information

Drug General Information
Drug ID
D0L4HL
Former ID
DNCL003112
Drug Name
RG7314
Indication Autism [ICD9: 299; ICD10:F84.0] Phase 2 [524213]
Target and Pathway
Target(s) Vasopressin V1a receptor Target Info Modulator [544372]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Vascular smooth muscle contraction
Reactome Vasopressin-like receptors
G alpha (q) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
Peptide GPCRs
GPCR ligand binding
GPCR downstream signaling
References
Ref 524213ClinicalTrials.gov (NCT01793441) A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders. U.S. National Institutes of Health.
Ref 544372Social Communication is an Emerging Target for Pharmacotherapy in Autism Spectrum Disorder - A Review of the Literature on Potential Agents. J Can Acad Child Adolesc Psychiatry. 2014 February; 23(1):20-30.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.